XML 22 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenues:    
Total revenues $ 31,282 $ 28,805
Cost of revenues (exclusive of depreciation and amortization shown separately below) 30,864 23,591
Operating expenses:    
Research and development 18,554 21,351
General and administrative 40,766 35,382
Depreciation and amortization 10,715 3,363
Impairment of assets 15,246 0
Total operating expenses 85,281 60,096
Loss from operations (84,863) (54,882)
Other income (expenses):    
Investment income 6,783 6,303
Interest expenses (371) (131)
Gain in fair value of derivatives 290 69
(Loss) gain in fair value of common stock warrants liability (3,225) 29,531
(Loss) gain in fair value of earnout liability (703) 40,983
Other (expenses) income, net (939) 838
Total other income, net 1,835 77,593
(Loss) income before income tax (provision) benefit (83,028) 22,711
Income tax (provision) benefit (669) 1,087
Net (loss) income (83,697) 23,798
Other comprehensive income (loss):    
Unrealized gain on marketable securities 2,197 6,355
Foreign currency translation adjustment (12,974) 3,666
Total other comprehensive (loss) income (10,777) 10,021
Total comprehensive (loss) income $ (94,474) $ 33,819
Net (loss) income per share, basic (in dollars per share) $ (0.58) $ 0.17
Net (loss) income per share, diluted (in dollars per share) $ (0.58) $ 0.17
Weighted-average common shares outstanding, basic (in shares) 143,192,630 139,718,385
Weighted-average common shares outstanding, diluted (in shares) 143,192,630 142,658,423
Products    
Revenues:    
Total revenues $ 31,279 $ 23,896
Services    
Revenues:    
Total revenues $ 3 $ 4,909